Beranda › Kanker Sel Germinal dan Embrio
Uji klinis Kanker Sel Germinal dan Embrio yang merekrut di AS
21 studi untuk Kanker Sel Germinal dan Embrio merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX6 studi
- Columbus, OH5 studi
- New York City, NY5 studi
- St. Louis, MO4 studi
- Indianapolis, IN4 studi
- Chicago, IL4 studi
- Memphis, TN3 studi
- Winston-Salem, NC3 studi
- Greenburgh, NY3 studi
- Dallas, TX3 studi
- Boston, MA3 studi
- San Francisco, CA3 studi
- Mountain View, CA3 studi
- Clifton, NJ3 studi
- Minneapolis, MN3 studi
- San Antonio, TX3 studi
- San Bernardino, CA3 studi
Berdasarkan negara bagian
- California7 studi
- Florida3 studi
- Georgia3 studi
- Illinois4 studi
- Indiana4 studi
- Massachusetts3 studi
- Michigan3 studi
- Minnesota3 studi
- Missouri4 studi
- New Jersey4 studi
- New York6 studi
- North Carolina3 studi
- Ohio5 studi
- Pennsylvania3 studi
- Tennessee4 studi
- Texas7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Menerima pesertaFase 3
Usia 11 hingga 50 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Menerima pesertaFase 3
Semua usia · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06276491Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Menerima pesertaFase 1/2
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05092451C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Menerima pesertaFase 1
12 Months – 25 Years · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04099797Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07628634A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06866964Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Menerima pesertaFase 1/2
Usia 4 hingga 39 · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT05278208Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 10 Jul 2026 · NCT06828185A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Menerima pesertaFase 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04897321Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT04804007A Study of ZW251 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT07164313A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Menerima pesertaFase awal 1
Usia 3 hingga 21 · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT07017816Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Menerima pesertaFase 1
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04308330The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT01890486Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Menerima pesertaFase 1
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT04185038Germ Cell Tumor and Testicular Tumor DNA Registry
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT02099734Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT06937866Molecular Epidemiology of Pediatric Germ Cell Tumors
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT05564026Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.